JVLAX | VIVIX | JVLAX / VIVIX | |
Total Expense Ratio | 0.96 | 0.04 | 2,400% |
Annual Report Gross Expense Ratio | 0.97 | 0.04 | 2,425% |
Fund Existence | 17 years | 27 years | - |
Gain YTD | 8.235 | 6.215 | 133% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.1B | 189B | 10% |
Annual Yield % from dividends | 0.68 | 2.19 | 31% |
Returns for 1 year | 0.65 | 12.05 | 5% |
Returns for 3 years | 18.54 | 35.17 | 53% |
Returns for 5 years | 47.96 | 80.14 | 60% |
Returns for 10 years | 38.33 | 115.68 | 33% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HFND | 22.33 | 0.12 | +0.56% |
Unlimited HFND Multi-Strgy Ret Trckr ETF | |||
BSJR | 22.78 | 0.09 | +0.40% |
Invesco BulletShares 2027 HY Corp Bd ETF | |||
AAVM | 27.03 | 0.08 | +0.30% |
Alpha Architect Global Factor Equity ETF | |||
PSCH | 40.31 | 0.09 | +0.22% |
Invesco S&P SmallCap Health Care ETF | |||
ISTB | 48.38 | -0.05 | -0.10% |
iShares Core 1-5 Year USD Bond ETF |